Thromboembolism Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Thromboembolism 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Thromboembolism 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Thromboembolism Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Boehringer Ingelheim GmbH 38
Clinical Trial Overview of Boehringer Ingelheim GmbH 38
Sanofi 40
Clinical Trial Overview of Sanofi 40
Astellas Pharma Inc. 42
Clinical Trial Overview of Astellas Pharma Inc. 42
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
Daiichi Sankyo Company, Limited 45
Clinical Trial Overview of Daiichi Sankyo Company, Limited 45
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Bristol-Myers Squibb Company 47
Clinical Trial Overview of Bristol-Myers Squibb Company 47
Portola Pharmaceuticals, Inc. 48
Clinical Trial Overview of Portola Pharmaceuticals, Inc. 48
Boehringer Ingelheim Pharmaceuticals, Inc. 49
Clinical Trial Overview of Boehringer Ingelheim Pharmaceuticals, Inc. 49
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Daiichi Sankyo, Inc. 51
Clinical Trial Overview of Daiichi Sankyo, Inc. 51
Isis Pharmaceuticals, Inc. 52
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 52
LEO Pharma A/S 53
Clinical Trial Overview of LEO Pharma A/S 53
ThromboGenics NV 54
Clinical Trial Overview of ThromboGenics NV 54
Eisai Inc. 55
Clinical Trial Overview of Eisai Inc. 55
MEDRAD Interventional/POSSIS 56
Clinical Trial Overview of MEDRAD Interventional/POSSIS 56
ARYx Therapeutics, Inc. 57
Clinical Trial Overview of ARYx Therapeutics, Inc. 57
Medco Health Solutions Inc. (Inactive) 58
Clinical Trial Overview of Medco Health Solutions Inc. (Inactive) 58
Clinical Trial Overview of Top Universities / Institutes / Hospitals 59
Ottawa Hospital Research Institute 59
Clinical Trial Overview of Ottawa Hospital Research Institute 59
Beijing Chao Yang Hospital 60
Clinical Trial Overview of Beijing Chao Yang Hospital 60
Utrecht University 61
Clinical Trial Overview of Utrecht University 61
University of Calgary 62
Clinical Trial Overview of University of Calgary 62
University of Padua 63
Clinical Trial Overview of University of Padua 63
University of Zurich 64
Clinical Trial Overview of University of Zurich 64
The University of Utah 65
Clinical Trial Overview of The University of Utah 65
Mayo Clinic 66
Clinical Trial Overview of Mayo Clinic 66
Brigham and Women's Hospital 67
Clinical Trial Overview of Brigham and Women's Hospital 67
Universita degli Studi dell'Insubria 68
Clinical Trial Overview of Universita degli Studi dell'Insubria 68
The University of Texas M. D. Anderson Cancer Center 69
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 69
Assistance Publique - Hopitaux de Paris 70
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 70
Johann Wolfgang Goethe University Hospitals 71
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 71
Washington University School of Medicine 72
Clinical Trial Overview of Washington University School of Medicine 72
Stanford University 73
Clinical Trial Overview of Stanford University 73
University Hospital Basel 74
Clinical Trial Overview of University Hospital Basel 74
Hadassah Medical Organization 75
Clinical Trial Overview of Hadassah Medical Organization 75
Leiden University Medical Center 76
Clinical Trial Overview of Leiden University Medical Center 76
Odense University Hospital 77
Clinical Trial Overview of Odense University Hospital 77
McMaster University 78
Clinical Trial Overview of McMaster University 78
Five Key Clinical Profiles 79
Appendix 137
Abbreviations 137
Definitions 137
Research Methodology 138
Secondary Research 138
About GlobalData 139
Contact Us 139
Disclaimer 139
Source 139
List of Tables
List of Tables
Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Thromboembolism Global Clinical Trials Review, H1, 2013 published by GlobalData in February 15, 2013. This report consists of Pages: 139 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
